Enfermedad de Parkinson: fisiopatología y nuevos tratamientos
University of Cambridge
Cambridge, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Cambridge (6)
2019
-
Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 11, pp. 301-309
2017
-
Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update
The Lancet Neurology, Vol. 16, Núm. 3, pp. 238-250
-
Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility
European Journal of Neurology, Vol. 24, Núm. 2, pp. 357-365
2016
-
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Science Translational Medicine, Vol. 8, Núm. 341
2015
-
Dopaminergic modulation of the trade-off between probability and time in economic decision-making
European Neuropsychopharmacology, Vol. 25, Núm. 6, pp. 817-827
-
Successful working memory processes and cerebellum in an elderly sample: A neuropsychological and fMRI study
PLoS ONE, Vol. 10, Núm. 7